<DOC>
<DOCNO>EP-0633258</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Improved process for the production of astaxanthin, new intermediates therefor and a process for their production
</INVENTION-TITLE>
<CLASSIFICATIONS>C07F900	C07C40300	C07C4900	C07D31700	C07C4118	C07D40706	C07D31754	C07D40712	C09B2310	C09B2300	C07D40700	C07C4100	C07F954	C07C40324	C07C49303	C07D31746	C07D31750	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07F	C07C	C07C	C07D	C07C	C07D	C07D	C07D	C09B	C09B	C07D	C07C	C07F	C07C	C07C	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07F9	C07C403	C07C49	C07D317	C07C41	C07D407	C07D317	C07D407	C09B23	C09B23	C07D407	C07C41	C07F9	C07C403	C07C49	C07D317	C07D317	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Compounds of the general formula I 
<
IMAGE
>
  in which     R
<
1
>
 is H or C1-C4-alkyl, R
<
2
>
 is C1-C4-alkyl and R
<
3
>
 is an ether, silyl ether or acetal protective group which can be converted into a hydroxyl group by hydrolysis, in particular one of the radicals 
<
IMAGE
>
   and a process for the production of these compounds by reacting an alkenyne of the general formula II 
<
IMAGE
>
 in an inert solvent with additional use of lithium amide with a cyclohexenone of the general formula III 
<
IMAGE
>
 and the use of the compounds of the formula I for the production of astaxanthin.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
A compound of the formula I 

 
where 


R
1
 is H or C
1
-C
4
-alkyl, 
R
2
 is C
1
-C
4
-alkyl and 
R
3
 is an ether, silyl ether or acetal protective group 
which can be converted into a hydroxyl group by hydrolysis. 
A compound of the formula I as claimed in 
claim 1, where R
1
 and R
2
 have the meanings stated in 
claim 1, and R
3
 is one of the radicals 

A process for preparing a compound of the 
formula I  

 

 
where 


R
1
 is H or C
1
-C
4
-alkyl, 
R
2
 is C
1
-C
4
-alkyl and 
R
3
 is an ether, silyl ether or acetal protective group 
which can be converted into a hydroxyl group by hydrolysis, 

which comprises reacting an alkenyne of the 
formula II 


 
where R
3
 has the abovementioned meanings, in an inert 
solvent in the presence of lithium amide with a 

cyclohexenone of the formula III 

 
where R
1
 and R
2
 have the abovementioned meanings. 
A process as claimed in claim 3, wherein the 
reaction is carried out in methyl tert-butyl ether as 

inert solvent. 
A process as claimed in claim 3, wherein the 
alkenyne of the formula II is employed in an excess of 

from 0 to 100 mol % based on the cyclohexenone of the  
 

formula III. 
A process as claimed in claim 3, wherein the 
reaction is carried out at from room temperature to the 

boiling point of the solvent used. 
The use of a compound as claimed in claim 1 
for preparing 6-hydroxy-3-(3-hydroxy-3-methyl-1,4-pentadien-1-yl)-2,4,4-trimethyl-2-cyclohexen-1-one 

of 
the formula IV 


The use of a compound as claimed in claim 1 
for preparing astaxanthin of the formula V 


A process for preparing astaxanthin of the 
formula V, which comprises 


A. reacting an alkenyne of the formula II 

 
where
 
R
3
 is an ether, silyl ether or acetal protective 
group which can be converted into a hydroxyl group 

by hydrolysis, in an inert solvent in the presence 
of lithium amide with a cyclohexenone of the 

formula III  
 


 
where 


R
1
 is H or C
1
-C
4
-alkyl and 
R
2
 is C
1
-C
4
-alkyl, 
B. eliminating from the resulting tertiary alcohol of 
the formula I 


 
the protective groups in aqueous acidic medium, 
C. reducing the resulting alkynediol of the formula 
VI 


 
with zinc dust in methylene chloride/acetic acid, 
D. reacting the resulting C
15
-diol of the formula IV 

 
with hydrochloric acid or hydrobromic acid, 
E. reacting the resulting halide of the formula VII  
 


 
where X is Cl or Br,
 
with triphenylphosphine, and 
F. subjecting the resulting triphenylphosphonium salt 
of the formula VIII 


 
where X is Cl or Br,
 
to a Wittig reaction with 2,7-dimethyl-2,4,6-octatrienedial 

to give astaxanthin. 
A process for preparing astaxanthin of the 
formula V as claimed in claim 9, wherein stages C., D., 

E. and F. are carried out without isolating the intermediates 
of the formula IV, VII and VIII. 
</CLAIMS>
</TEXT>
</DOC>
